ACRS
Aclaris Therapeutics, Inc. · Healthcare
Director Stephen A. Tullman bought $100K of Aclaris Therapeutics, Inc.
Bought$99,813
$15.97Price
6,250Shares
+1%Stake
What ACRS did for a copier
Prices for ACRS after this filing aren't in yet.
Stephen A. Tullman's record
3 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 15. Filed Fri, Aug 17, 12:55 PM ET, during the session. Not investment advice.